MALAT1
Species: Homo sapiens
Position: chr11: 65497687-65506516
Known as: MALAT1 , ENSG00000251562
Transcript: NR_002819 , NR_144567 , NR_144568 , ENST00000534336 , ENST00000619449
Sequence: Download
Description:
MALAT1 (metastasis associated lung adenocarcinoma transcript 1) is upregulated in many cancers, such as breast, pancreatic, lung, colon, prostate and liver cancer, and could inhibit tumor cell apoptosis and promote cell invasion in bladder cancer. Using "CRISPR Activation" (CRISPRa) and "CRISPR Interference" (CRISPRi) to up- and down-regulate MALAT1 expression, a reciprocal repression feedback loop between miR-125b and MALAT1 was found. Besides, due to the high expression in a variety of cell lines, MALAT1 is frequently used as representative lncRNA to develop CRISPR-cas9 techniques, like Crispr/Cas9-based HDR-mediated biallelic integration of poly(A), paired gRNA-guided CRISPR/Cas9 knockout (paired-KO) method, Double Excision CRISPR Knockout (DECKO), etc.
sgRNAs
sgRNA_ID | Sequence | Position (Chr) | Position (Lnc) | Length | PAM | Type | Validity | Cell line | Note | Ref. |
---|---|---|---|---|---|---|---|---|---|---|
sgRNA1 | GCTGCGTCAGGGACAAACGC | 65497676-65497695(-) | gene body (near 5') | 20 | CGG | CRISPRa | Experimental validated | T24 | NA | [1] |
sgRNA2 | GGAGGGACTGCGCAACCGGT | 65497699-65497718(-) | gene body (near 5') | 20 | GGG | CRISPRa | High activity | T24 | significant increases in MALAT1 expression | [1] |
sgRNA3 | GGCGCTGCGCTTAAGAGGGC | 65497796-65497815(-) | gene body (near 5') | 20 | AGG | CRISPRi | Experimental validated | T24 | NA | [1] |
sgRNA4 | GGGCTTCTGCGTTGCTAAAA | 65497817-65497836(-) | gene body (near 5') | 20 | TGG | CRISPRi | High activity | T24;K562 | yielded >85% knockdown | [1] [2] |
sgRNA5 | GGCAGGAGAGGCCAGTTGCG | 65497779-65497798(-) | gene body (near 5') | 20 | GGG | CRISPRi;CRISPRko | High activity | T24;Hela;HEK293T;IMR90;HCT116 | highest repression observed,paried with sgRNA7 | [1] [3] |
sgRNA6 | GCAACGCAGAAGCCCGGCGC | 65497822-65497841(+) | gene body (near 5') | 20 | CGG | CRISPRki | Experimental validated | HEK293 | NA | [4] |
sgRNA7 | CGTGTAGCTATCAAGGGCCA | 65497234-65497253(-) | up stream | 20 | TGG | CRISPRko | High activity | U937;HEK293;Hela;HEK293T;IMR90;HCT116 | paried with sgRNA5,8 | [5] [3] |
sgRNA8 | CCTACCGCACAGCTCGGGCG | 65499028-65499047(-) | gene body (near 5') | 20 | AGG | CRISPRko | Experimental validated | U937;HEK293 | paried with sgRNA7 | [5] |
sgRNA9 | CAGCTGTTCTCAATTGACGC | 65496729-65496748(-) | up stream | 20 | TGG | CRISPRko | Experimental validated | hPSCs | paried with sgRNA10 | [6] |
sgRNA10 | AAAATGGCGCTGCGCTTAAG | 65497801-65497820(-) | gene body (near 5') | 20 | AGG | CRISPRi;CRISPRko | High activity | hPSCs;Hela | successfully yielded biallelic deletions with high efficiency,paried with sgRNA9,11,12,13,14 | [6] [7] |
sgRNA11 | GACAAAGCCATTCGCTTAGT | 65498201-65498220(+) | gene body (near 5') | 20 | TGG | CRISPRko | High activity | hPSCs | successfully yielded biallelic deletions with high efficiency,paried with sgRNA10 | [6] |
sgRNA12 | GCTGGGGCTCAGTTGCGTAA | 65498615-65498634(+) | gene body (near 5') | 20 | TGG | CRISPRko | High activity | hPSCs;MDA-MB-231 | successfully yielded biallelic deletions with high efficiency,paried with sgRNA10,17 | [6] [3] [8] |
sgRNA13 | TTGGTAAAAATCCGTGAGGT | 65500761-65500780(+) | gene body (near 5') | 20 | CGG | CRISPRko | High activity | hPSCs | successfully yielded biallelic deletions with high efficiency,paried with sgRNA10 | [6] |
sgRNA14 | TTCAAGTAGGGTACGGACTT | 65506590-65506609(+) | down stream | 20 | TGG | CRISPRko | Experimental validated | hPSCs | paried with sgRNA10 | [6] |
sgRNA15 | CCAACTTCCATTTTCAGTCT | 65497346-65497365(-) | up stream | 20 | AGG | CRISPRko | Experimental validated | Hela;HEK293T;IMR90;HCT116 | paried with sgRNA16 | [3] |
sgRNA16 | GGAAGCCTCAGCTCGCCTGA | 65497844-65497863(+) | gene body (near 5') | 20 | AGG | CRISPRko | Experimental validated | Hela;HEK293T;IMR90;HCT116 | paried with sgRNA15 | [3] |
sgRNA17 | AGGTTTCTAAAACATGACGG | 65499284-65499303(+) | gene body (near 5') | 20 | AGG | CRISPRko | High activity | Hela;HEK293T;IMR90;HCT116;MDA-MB-231 | paried with sgRNA12 | [3] [8] |
sgRNA18 | GTTGAGATGAAGCTTCTTCA | 65499306-65499325(+) | gene body (near 5') | 20 | TGG | CRISPRko | Experimental validated | Hela;HEK293T;IMR90;HCT116 | paried with sgRNA19 | [3] |
sgRNA19 | TCAACCGTCCCTGCAAGGCT | 65498598-65498617(+) | gene body (near 5') | 20 | GGG | CRISPRko | Experimental validated | Hela;HEK293T;IMR90;HCT116 | paried with sgRNA18 | [3] |
sgRNA20 | CAAACCTCGTGTAGCTATCA | 65497241-65497260(-) | up stream | 20 | AGG | CRISPRko | Experimental validated | Hela;HEK293T;IMR90;HCT116 | paried with sgRNA21 | [3] |
sgRNA21 | AATGTGAAGGACTTTCGTAA | 65500266-65500285(+) | gene body (near 5') | 20 | CGG | CRISPRko | Experimental validated | Hela;HEK293T;IMR90;HCT116 | paried with sgRNA20 | [3] |
sgRNA22 | AAGGACTGGGGCCCCGCAAC | 65497765-65497784(+) | gene body (near 5') | 20 | TGG | CRISPRi | Experimental validated | Hela | NA | [7] |
sgRNA23 | GCAGCCCGAGACTTCTGTAA | 65497746-65497765(+) | gene body (near 5') | 20 | AGG | CRISPRi | Experimental validated | Hela | NA | [7] |
sgRNA24 | GCGCTGCGCTTAAGAGGGC | 65497796-65497814(-) | gene body (near 5') | 19 | AGG | CRISPRi | Experimental validated | K562 | NA | [2] |
sgRNA25 | CCGCAGATCAGAGTGGGCCAC | 65498358-65498378(+) | gene body (near 5') | 21 | TGG | CRISPRko | Experimental validated | Huh7.5 | paried with sgRNA26 | [9] |
sgRNA26 | GGATAGTACACTTCACTCAG | 65503381-65503400(+) | gene body (near 3') | 20 | AGG | CRISPRko | Experimental validated | Huh7.5 | paried with sgRNA25 | [9] |
sgRNA27 | ACACAAGAAGTGCTTTAAG | 65498714-65498732(+) | gene body (near 5') | 19 | AGG | CRISPRko | Experimental validated | Huh7.5 | paried with sgRNA28 | [9] |
sgRNA28 | GGGATCAAGTGGATTGAGG | 65503062-65503080(+) | gene body (near 3') | 19 | AGG | CRISPRko | Experimental validated | Huh7.5 | paried with sgRNA27 | [9] |
sgRNA29 | CCCGAATTAATACCAATAGA | 65499376-65499395(+) | gene body (near 5') | 20 | AGG | CRISPRko | Experimental validated | Huh7.5 | paried with sgRNA30 | [9] |
sgRNA30 | CTTGAATGTCTCTTAGAGGG | 65502571-65502590(+) | gene body (near 3') | 20 | TGG | CRISPRko | Experimental validated | Huh7.5 | paried with sgRNA29 | [9] |
sgRNA31 | CCCATCAATTTAATTTCTGG | 65500026-65500045(+) | gene body (near 5') | 20 | TGG | CRISPRko | Experimental validated | Huh7.5 | paried with sgRNA32 | [9] |
sgRNA32 | CCAGTTTGAATTGGGAAGCT | 65502038-65502057(+) | gene body (near 5') | 20 | GGG | CRISPRko | Experimental validated | Huh7.5 | paried with sgRNA31 | [9] |
sgRNA33 | GAGCCAGTGCGATTTGGTGA | 65500537-65500556(+) | gene body (near 5') | 20 | AGG | CRISPRko | Experimental validated | Huh7.5 | paried with sgRNA34 | [9] |
sgRNA34 | GGTCTTAACAGGGAAGAGAG | 65501532-65501551(+) | gene body (near 5') | 20 | AGG | CRISPRko | Experimental validated | Huh7.5 | paried with sgRNA33 | [9] |
sgRNA35 | CTAGAGCCGGTTAGAACCAG | 65497562-65497581(+) | up stream | 20 | TGG | CRISPRko | Experimental validated | HEK293T, Jurkat T | paried with sgRNA36 | [10] |
sgRNA36 | AACCGGTGGGGCTGCGTCAGG | 65497685-65497705(-) | gene body (near 5') | 21 | GAC | CRISPRko | Experimental validated | HEK293T, Jurkat T | paried with sgRNA35 | [10] |
GBrowser
Links
Reference
1. Xie H, Liao X, Chen Z, Fang Y, He A, et al. (2017). LncRNA MALAT1 Inhibits Apoptosis and Promotes Invasion by Antagonizing miR-125b in Bladder Cancer Cells. J Cancer 8(18): 3803-3811.
2. Gilbert LA, Horlbeck MA, Adamson B, Villalta JE, Chen Y, et al. (2014). Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation. Cell 159(3): 647-61.
3. Aparicio-Prat E, Arnan C, Sala I, Bosch N, Guigó R, et al. (2015). DECKO: Single-oligo, dual-CRISPR deletion of genomic elements including long non-coding RNAs. BMC Genomics 16: 846.
4. Liu Y, Han X, Yuan J, Geng T, Chen S, et al. (2017). Biallelic insertion of a transcriptional terminator via the CRISPR/Cas9 system efficiently silences expression of protein-coding and non-coding RNA genes. J Biol Chem 292(14): 5624-5633.
5. Janga H, Aznaourova M, Boldt F, Damm K, Grünweller A, et al. (2018). Cas9-mediated excision of proximal DNaseI/H3K4me3 signatures confers robust silencing of microRNA and long non-coding RNA genes. PLoS One 13(2): e0193066.
6. Liu Z, Hui Y, Shi L, Chen Z, Xu X, et al. (2016). Efficient CRISPR/Cas9-Mediated Versatile, Predictable, and Donor-Free Gene Knockout in Human Pluripotent Stem Cells. Stem Cell Reports 7(3): 496-507.
7. Stojic L, Lun ATL, Mangei J, Mascalchi P, Quarantotti V, et al. (2018). Specificity of RNAi, LNA and CRISPRi as loss-of-function methods in transcriptional analysis. Nucleic Acids Res.
8. Kim J, Piao HL, Kim BJ, Yao F, Han Z, et al. (2018). Long noncoding RNA MALAT1 suppresses breast cancer metastasis. Nat Genet 50(12): 1705-1715.
9. Zhu S, Li W, Liu J, Chen CH, Liao Q, et al. (2016). Genome-scale deletion screening of human long non-coding RNAs using a paired-guide RNA CRISPR-Cas9 library. Nat Biotechnol 34(12): 1279-1286.
10. Qu D, Sun WW, Li L, Ma L, Sun L, et al. (2019). Long noncoding RNA MALAT1 releases epigenetic silencing of HIV-1 replication by displacing the polycomb repressive complex 2 from binding to the LTR promoter. Nucleic Acids Res 47(6): 3013-3027.